About Ombitasvir,Paritaprevir,Ritonavir
Class: | Antiviral combination (Ombitasvir: NS5A inhibitor, Paritaprevir: NS3/4A protease inhibitor, Ritonavir: CYP3A inhibitor)
Use: | Treatment of chronic hepatitis C virus (HCV) genotype 1 infection in adults, in combination with other antiviral medications.
Adult dose: | The standard dose is two tablets taken once daily with food, in combination with dasabuvir (250 mg twice daily) for 12 or 24 weeks, depending on the patient's HCV genotype and prior treatment history.
Pediatric dose: | Not a
Drug Class
Antiviral combination (Ombitasvir: NS5A inhibitor, Paritaprevir: NS3/4A protease inhibitor, Ritonavir: CYP3A inhibitor)
Uses & Indications
Treatment of chronic hepatitis C virus (HCV) genotype 1 infection in adults, in combination with other antiviral medications.
Storage Requirements
Store at room temperature between 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
Manufacturer & Packaging
Manufacturer: AbbVie Deutschland GmbH & Co. KG, GERMANY
Package Size
56's (14's pack x 4)
Price & Supplier
Price in UAE: AED 88950.00
Dosage Information
Adult Dose
The standard dose is two tablets taken once daily with food, in combination with dasabuvir (250 mg twice daily) for 12 or 24 weeks, depending on the patient's HCV genotype and prior treatment history.
Pediatric Dose
Not applicable; safety and efficacy have not been established in pediatric patients.
Side Effects
Common side effects include fatigue, nausea, pruritus, insomnia, and asthenia.
Contraindications & Precautions
Contraindicated in patients with severe hepatic impairment (Child-Pugh C), those taking drugs highly dependent on CYP3A for clearance, and those with known hypersensitivity to any component of the product.
Important Warnings
Risk of hepatic decompensation and hepatic failure in patients with cirrhosis; monitor liver function tests before and during treatment. Caution in patients with a history of liver disease. Potential for drug interactions due to CYP3A inhibition by ritonavir.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.